HUM vs IMNN · P/E 39, rev $117.76B vs rev $500.0K
Humana Inc (HUM) versus Imunon Inc (IMNN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Imunon Inc (IMNN) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. IMNN currently screens at market cap $9.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IMNN currently screens at market cap $9.2M.
Not investment advice. Open the HUM and IMNN stock pages for the full models.
Not investment advice.